Please login to the form below

Not currently logged in
Email:
Password:

Lilly bolsters its oncology team

Kimberly Blackwell is appointed VP early phase development, immuno-oncology

Eli Lilly and Company has strengthened its oncology team with the addition of Kimberly Blackwell, who joins the pharma group as its new vice president of early phase development and immuno-oncology.

Blackwell currently serves as a professor of medicine and assistant professor of radiation oncology at Duke University Medical Center, and she is also the co-director of the Duke women’s cancer programme, associate director for strategic relations for the Duke Cancer Institute among other roles.

Sue Mahon, senior vice president and president of Lilly Oncology, said: “We are pleased and honoured to welcome Dr Blackwell to Lilly, she is a highly regarded for her leadership in cancer research, especially metastatic breast cancer, where she has led programmes that resulted in numerous ground-breaking regulatory approvals.

“Furthermore, she has been on the forefront of research in oncology vaccines, immuno-oncology and biosimilars, giving her the unique expertise that will be pivotal in helping us continue to develop and advance novel treatments for people living with cancer.”

15th January 2018

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics